Stephen A Hill

CIK 1237404 · View on SEC EDGAR ↗

Insider

First SEC filing: Aug. 18, 2014 · Latest: Aug. 18, 2014

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 22 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

22 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
June 4, 2020 CLRB P 18,000 $1.08 $19,440 18,000 Direct — Acquired -99.2% (price as of 2026-08-18)
Nov. 29, 2018 CLRB S 530 $0.05 $26 0 Direct — Acquired -82.7% (price as of 2026-08-18)
Nov. 29, 2018 CLRB S 9,390 $0.10 $939 0 Direct — Acquired -91.3% (price as of 2026-08-18)
Nov. 29, 2018 CLRB S 53 $2.21 $117 0 Direct -100.00% Disposed -99.6% (price as of 2026-08-18)
Nov. 29, 2018 CLRB S 939 $2.21 $2,075 53 Direct -94.66% Disposed -99.6% (price as of 2026-08-18)
April 20, 2016 CLRB P 9,390 $0.01 $94 9,920 Direct +1771.70% Acquired -91.3% (price as of 2026-08-18)
April 20, 2016 CLRB P 9,390 $2.12 $19,907 9,920 Direct +1771.70% Acquired -100.0% (price as of 2026-08-18)
Dec. 17, 2015 GYRE P 5,000 $2.03 $10,150 20,711 Direct +31.82% Acquired -98.5% (price as of 2026-08-18)
Nov. 13, 2014 LPCN P 4,000 $4.95 $19,800 4,000 Direct — Acquired -97.5% (price as of 2026-08-18)
Aug. 20, 2014 CLRB P 5,300 $0.01 $53 21,351 Direct +33.02% Acquired -99.1% (price as of 2026-08-18)
Aug. 20, 2014 CLRB P 5,300 $3.75 $19,875 5,300 Direct — Acquired -100.0% (price as of 2026-08-18)
March 11, 2013 GYRE P 10,000 $4.38 $43,800 20,000 Direct +100.00% Acquired -99.9% (price as of 2026-08-18)
March 11, 2013 GYRE P 10,000 $4.38 $43,800 20,000 Direct +100.00% Acquired -99.9% (price as of 2026-08-18)
March 8, 2013 GYRE P 10,000 $4.48 $44,800 10,000 Direct — Acquired -99.9% (price as of 2026-08-18)
March 8, 2013 GYRE P 10,000 $4.48 $44,800 10,000 Direct — Acquired -99.9% (price as of 2026-08-18)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
June 24, 2020 CLRB Stock option (right to buy) Common Stock (50,000) $1.28 June 24, 2030 50,000 Acquired
June 13, 2019 CLRB Stock option (right to buy) Common Stock (6,500) $2.15 June 13, 2029 6,500 Acquired
Nov. 29, 2018 CLRB Warrants Common Stock (530) $468.00 Aug. 20, 2019 530 Acquired
Nov. 29, 2018 CLRB Series A Warrants Common Stock (9,390) $30.40 April 20, 2021 9,390 Acquired
Oct. 12, 2018 CLRB Stock option (right to buy) Common Stock (13,000) $2.61 Oct. 12, 2028 13,000 Acquired
June 13, 2018 GYRE Stock Option (Right to Buy) Common Stock (5,000) $24.94 June 13, 2028 5,000 Acquired
Feb. 20, 2018 GYRE Redeemable Convertible Note Common Stock (156) — — 21,600 Disposed
Feb. 20, 2018 GYRE Redeemable Convertible Note Common Stock (1,371) — — — Disposed
July 13, 2017 GYRE Stock Option (Right to Buy) Common Stock (10,000) $4.40 July 13, 2027 10,000 Acquired
May 31, 2017 CLRB Stock option (right to buy) Common Stock (10,000) $1.74 May 31, 2027 10,000 Acquired
July 5, 2016 CLRB Stock option (right to buy) Common Stock (22,500) $3.34 July 5, 2026 22,500 Acquired
June 9, 2016 GYRE Stock Option (Right to Buy) Common Stock (7,500) $1.88 June 9, 2026 7,500 Acquired
April 20, 2016 CLRB Series A Warrants Common Stock (9,390) $3.04 April 20, 2021 9,390 Acquired
Oct. 22, 2015 GYRE Stock Option (Right to Buy) Common Stock (6,750) $4.40 Oct. 22, 2025 6,750 Acquired
Oct. 22, 2015 GYRE Stock Option (Right to Buy) Common Stock (6,750) $4.40 Oct. 22, 2025 6,750 Acquired
Oct. 22, 2015 GYRE Stock Option (Right to Buy) Common Stock (8,250) $4.40 Oct. 22, 2025 8,250 Acquired
Aug. 14, 2015 GYRE Redeemable Convertible Note Common Stock (160,608) $1.31 — — Acquired
June 16, 2015 LPCN Stock Option (Right to Buy) Common Stock (20,000) $7.29 June 15, 2025 20,000 Acquired
June 9, 2015 CLRB Stock option (right to buy) Common Stock (5,000) $2.64 June 9, 2025 5,000 Acquired
Aug. 20, 2014 CLRB Stock purchase warrant (right to buy) Common Stock (5,300) $4.68 Aug. 20, 2019 5,300 Acquired
Jan. 23, 2014 GYRE Stock Option (Right to Buy) Common Stock, $0.001 par value per share (175,000) $4.74 Jan. 22, 2024 175,000 Acquired
Jan. 6, 2014 LPCN Stock Option (Right to Buy) Common Stock (10,000) $8.25 Jan. 6, 2024 10,000 Acquired
Dec. 3, 2012 GYRE Stock Option (Right to Buy) Common Stock (400,000) $4.50 Dec. 2, 2022 400,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 10 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
Aug. 18, 2014 CLRB Stock Option (right to buy)→ Common Stock (3,750) 3,750 Direct
Aug. 18, 2014 CLRB Stock Option (right to buy)→ Common Stock (3,750) 3,750 Direct
Aug. 18, 2014 CLRB Stock Option (right to buy)→ Common Stock (3,750) 3,750 Direct
Aug. 18, 2014 CLRB Stock Option (right to buy)→ Common Stock (7,500) 7,500 Direct
Aug. 18, 2014 CLRB Stock Option (right to buy)→ Common Stock (26) 26 Direct
Aug. 18, 2014 CLRB Stock Option (right to buy)→ Common Stock (26) 26 Direct
Aug. 18, 2014 CLRB Stock Option (right to buy)→ Common Stock (13) 13 Direct
Aug. 18, 2014 CLRB Stock Option (right to buy)→ Common Stock (49) 49 Direct
Jan. 8, 2014 LPCN Common Stock 0 Direct
Dec. 5, 2012 GYRE No securities are beneficially owned 0 Direct

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

GYRE

Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2015 $328,148 — — — — — $1,447,371 $1,841,519
2014 $515,000 $129,532 — — — — $10,775 $1,677,307
2013 $500,000 $187,500 — — — — $11,868 $699,368

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.